- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ADPM
Total 1264 results
-
University Hospital, GrenobleTerminatedKidney Failure, Chronic | Hypertension Resistant to Conventional TherapyFrance
-
MedSIRNot yet recruitingOvarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
-
Alexander B Olawaiye, MDAstraZenecaRecruiting
-
Azienda Ospedaliero-Universitaria di ModenaRecruitingMetastatic Pancreatic Cancer | Advanced Pancreatic CancerItaly
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
PfizerNot yet recruitingBreast Neoplasms
-
Hospices Civils de LyonNot yet recruitingAdvanced Malignant Pleural or Peritoneal Mesothelioma
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma InstituteRecruitingOsteosarcoma | Osteosarcoma RecurrentUnited States
-
pharmaand GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
Bai-Rong XiaActive, not recruiting
-
University of Colorado, DenverNational Cancer Institute (NCI); Clovis Oncology, Inc.Active, not recruitingMetastatic Endometrial CancerUnited States
-
University of FloridaGlaxoSmithKlineCompletedRenal Cell Carcinoma | Mesothelioma | Cholangiocarcinoma | Uveal MelanomaUnited States
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingMetastatic Cancer | Central Nervous System CancerUnited States
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Haihe Biopharma Co., Ltd.TerminatedBreast Cancer | Ovarian Cancer | Solid Tumor | Prostate Cancer | Endometrial CancerUnited States, Australia, China
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
GlaxoSmithKlineSuspendedNeoplasmsGermany, Spain, United Kingdom, France, Hungary, Czechia
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
Arcagy ResearchBelgian Gynaecological Oncology Group; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian CancerFrance, Germany, Austria, Denmark, Italy, Japan, Finland, Spain, Monaco, Sweden, Belgium
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Grupo Español de Investigación en Cáncer de OvarioCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
National Cancer Institute (NCI)Completed
-
University Hospital, CaenCompleted
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Laval UniversityTerminated
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
PfizerCompleted
-
Massachusetts General HospitalCompleted
-
Tesaro, Inc.WithdrawnLymphoma | Mantle-Cell
-
PfizerWithdrawnDiabetes Mellitus | Diabetic Retinopathy
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompleted
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Tesaro, Inc.Completed
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
zr Pharma & GmbHCompletedAdvanced Solid TumorsUnited Kingdom
-
University of Alabama at BirminghamWithdrawnOvarian Cancer RecurrentUnited States
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZenecaCompletedSolid TumorUnited States
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States, Canada
-
National Cancer Institute (NCI)Terminated